Warfarin Sodium
- Product NDC
- 57237-122
- Requested package NDC
- 57237-122-01
- 11-digit product format
- 572370122
- Labeler code
- 57237
- Product ID
- 57237-122_bab28da8-ce52-4caf-a5ef-8fa777aca739
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- warfarin sodium
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Rising Health, LLC
- Application
- ANDA090935
- Marketing category
- ANDA
- Marketing start
- 2011-11-11
- Marketing end
- 0000-00-00
- Substance
- WARFARIN SODIUM
- Active strength
- 3 mg/1
- Pharmacologic classes
- Vitamin K Antagonist [EPC],Vitamin K Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 57237-122 | 57237-122-01 | D | Discontinued by firm | 2026-08-17 |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A090935-001 | WARFARIN SODIUM | WARFARIN SODIUM | 1MG | TABLET / ORAL | AB | 2011-05-25 | |
| A090935-002 | WARFARIN SODIUM | WARFARIN SODIUM | 2MG | TABLET / ORAL | AB | 2011-05-25 | |
| A090935-003 | WARFARIN SODIUM | WARFARIN SODIUM | 2.5MG | TABLET / ORAL | AB | 2011-05-25 | |
| A090935-004 | WARFARIN SODIUM | WARFARIN SODIUM | 3MG | TABLET / ORAL | AB | 2011-05-25 | |
| A090935-005 | WARFARIN SODIUM | WARFARIN SODIUM | 4MG | TABLET / ORAL | AB | 2011-05-25 | |
| A090935-006 | WARFARIN SODIUM | WARFARIN SODIUM | 5MG | TABLET / ORAL | AB | 2011-05-25 | |
| A090935-007 | WARFARIN SODIUM | WARFARIN SODIUM | 6MG | TABLET / ORAL | AB | 2011-05-25 | |
| A090935-008 | WARFARIN SODIUM | WARFARIN SODIUM | 7.5MG | TABLET / ORAL | AB | 2011-05-25 | |
| A090935-009 | WARFARIN SODIUM | WARFARIN SODIUM | 10MG | TABLET / ORAL | AB | 2011-05-25 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A090935-001 | AB |
| A090935-002 | AB |
| A090935-003 | AB |
| A090935-004 | AB |
| A090935-005 | AB |
| A090935-006 | AB |
| A090935-007 | AB |
| A090935-008 | AB |
| A090935-009 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A090935-001 | WARFARIN SODIUM | 1MG | TABLET / ORAL | AB | 2011-05-25 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A090935-002 | WARFARIN SODIUM | 2MG | TABLET / ORAL | AB | 2011-05-25 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A090935-003 | WARFARIN SODIUM | 2.5MG | TABLET / ORAL | AB | 2011-05-25 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A090935-004 | WARFARIN SODIUM | 3MG | TABLET / ORAL | AB | 2011-05-25 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A090935-005 | WARFARIN SODIUM | 4MG | TABLET / ORAL | AB | 2011-05-25 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A090935-006 | WARFARIN SODIUM | 5MG | TABLET / ORAL | AB | 2011-05-25 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A090935-007 | WARFARIN SODIUM | 6MG | TABLET / ORAL | AB | 2011-05-25 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A090935-008 | WARFARIN SODIUM | 7.5MG | TABLET / ORAL | AB | 2011-05-25 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A090935-009 | WARFARIN SODIUM | 10MG | TABLET / ORAL | AB | 2011-05-25 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A090935-001 | WARFARIN SODIUM | 1MG | TABLET / ORAL | AB | 2011-05-25 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A090935-002 | WARFARIN SODIUM | 2MG | TABLET / ORAL | AB | 2011-05-25 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A090935-003 | WARFARIN SODIUM | 2.5MG | TABLET / ORAL | AB | 2011-05-25 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A090935-004 | WARFARIN SODIUM | 3MG | TABLET / ORAL | AB | 2011-05-25 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A090935-005 | WARFARIN SODIUM | 4MG | TABLET / ORAL | AB | 2011-05-25 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A090935-006 | WARFARIN SODIUM | 5MG | TABLET / ORAL | AB | 2011-05-25 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A090935-007 | WARFARIN SODIUM | 6MG | TABLET / ORAL | AB | 2011-05-25 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A090935-008 | WARFARIN SODIUM | 7.5MG | TABLET / ORAL | AB | 2011-05-25 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A090935-009 | WARFARIN SODIUM | 10MG | TABLET / ORAL | AB | 2011-05-25 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090935-001 | WARFARIN SODIUM | 1MG | TABLET / ORAL | AB | 2011-05-25 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090935-002 | WARFARIN SODIUM | 2MG | TABLET / ORAL | AB | 2011-05-25 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090935-003 | WARFARIN SODIUM | 2.5MG | TABLET / ORAL | AB | 2011-05-25 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090935-004 | WARFARIN SODIUM | 3MG | TABLET / ORAL | AB | 2011-05-25 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090935-005 | WARFARIN SODIUM | 4MG | TABLET / ORAL | AB | 2011-05-25 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090935-006 | WARFARIN SODIUM | 5MG | TABLET / ORAL | AB | 2011-05-25 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090935-007 | WARFARIN SODIUM | 6MG | TABLET / ORAL | AB | 2011-05-25 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090935-008 | WARFARIN SODIUM | 7.5MG | TABLET / ORAL | AB | 2011-05-25 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090935-009 | WARFARIN SODIUM | 10MG | TABLET / ORAL | AB | 2011-05-25 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A090935-001 | WARFARIN SODIUM | 1MG | TABLET / ORAL | AB | 2011-05-25 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A090935-002 | WARFARIN SODIUM | 2MG | TABLET / ORAL | AB | 2011-05-25 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A090935-003 | WARFARIN SODIUM | 2.5MG | TABLET / ORAL | AB | 2011-05-25 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A090935-004 | WARFARIN SODIUM | 3MG | TABLET / ORAL | AB | 2011-05-25 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A090935-005 | WARFARIN SODIUM | 4MG | TABLET / ORAL | AB | 2011-05-25 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A090935-006 | WARFARIN SODIUM | 5MG | TABLET / ORAL | AB | 2011-05-25 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A090935-007 | WARFARIN SODIUM | 6MG | TABLET / ORAL | AB | 2011-05-25 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A090935-008 | WARFARIN SODIUM | 7.5MG | TABLET / ORAL | AB | 2011-05-25 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A090935-009 | WARFARIN SODIUM | 10MG | TABLET / ORAL | AB | 2011-05-25 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A090935-001 | WARFARIN SODIUM | 1MG | TABLET / ORAL | AB | 2011-05-25 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A090935-002 | WARFARIN SODIUM | 2MG | TABLET / ORAL | AB | 2011-05-25 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A090935-003 | WARFARIN SODIUM | 2.5MG | TABLET / ORAL | AB | 2011-05-25 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A090935-004 | WARFARIN SODIUM | 3MG | TABLET / ORAL | AB | 2011-05-25 | fd3edfee7708… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A090935-001 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A090935-002 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A090935-003 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A090935-004 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A090935-005 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A090935-006 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A090935-007 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A090935-008 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A090935-009 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A090935-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A090935-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A090935-003 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A090935-004 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A090935-005 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A090935-006 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A090935-007 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A090935-008 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A090935-009 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090935-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090935-002 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090935-003 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090935-004 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090935-005 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090935-006 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090935-007 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090935-008 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090935-009 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A090935-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A090935-002 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A090935-003 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A090935-004 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A090935-005 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A090935-006 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A090935-007 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A090935-008 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A090935-009 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A090935-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A090935-002 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A090935-003 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A090935-004 | AB | 1 | fd3edfee7708… |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| abcfe2f4-1eca-fdc3-341b-b8134a1aec1f | Product name | 1 | 20140508 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 57237-122-01 | EA - Each | 57237-122 | ed53c6a1-d87d-4432-a002-7526bea1b97e | 1 | 2015-05-05 |
| 57237-122-99 | EA - Each | 57237-122 | 288d97a5-232c-45cf-8be8-30d6e5a5e267 | 1 | 2015-08-04 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| WARFARIN SODIUM | ACTIVE INGREDIENT | 6153CWM0CL | WARFARIN SODIUM TABLET [CITRON PHARMA LLC] | 2 | |
| WARFARIN | ACTIVE MOIETY | 5Q7ZVV76EI | WARFARIN SODIUM TABLET [CITRON PHARMA LLC] | 2 | |
| HYDROXYPROPYL CELLULOSE (TYPE H) | INACTIVE INGREDIENT | RFW2ET671P | WARFARIN SODIUM TABLET [CITRON PHARMA LLC] | 2 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | WARFARIN SODIUM TABLET [CITRON PHARMA LLC] | 2 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | WARFARIN SODIUM TABLET [CITRON PHARMA LLC] | 2 | |
| STARCH, CORN | INACTIVE INGREDIENT | O8232NY3SJ | WARFARIN SODIUM TABLET [CITRON PHARMA LLC] | 2 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Warfarin Sodium | WARFARIN | Aphena Pharma Solutions - Tennessee, LLC | 4f276251-49b7-438f-9c47-f1cdfc47e519 | 2026-01-22 | Boxed warning, Warnings, Adverse reactions | 090935 ANDA090935 |
| Warfarin Sodium | WARFARIN | Golden State Medical Supply, Inc. | a2f6c9f7-87dc-7428-e053-2995a90a1de6 | 2025-07-17 | Boxed warning, Warnings, Adverse reactions | 090935 ANDA090935 |
| WARFARIN SODIUM | WARFARIN SODIUM | DIRECT RX | c186d1ff-64dd-bfcb-e053-2a95a90af800 | 2025-01-17 | Boxed warning, Warnings, Adverse reactions | 090935 ANDA090935 |
| Warfarin Sodium | WARFARIN | Aphena Pharma Solutions - Tennessee, LLC | 52b3c2f6-b5ca-44ae-bdcc-552d5191034f | 2021-01-28 | Boxed warning, Warnings, Adverse reactions | 090935 ANDA090935 |
| Warfarin Sodium | WARFARIN | Aphena Pharma Solutions - Tennessee, LLC | a98916a5-cdb2-4251-bdea-0245c763b2f1 | 2020-12-15 | Boxed warning, Warnings, Adverse reactions | 090935 ANDA090935 |
| Warfarin Sodium | WARFARIN | Exelan Pharmaceuticals Inc. | c0cc4511-e656-4b6d-96cd-e02e76173b9d | 2020-09-09 | Boxed warning, Warnings, Adverse reactions | 090935 ANDA090935 |
| Warfarin Sodium | WARFARIN | Aphena Pharma Solutions - Tennessee, LLC | 91f24482-d4cb-4a09-a97e-64f6e49071ee | 2020-08-03 | Boxed warning, Warnings, Adverse reactions | 090935 ANDA090935 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 855318 | warfarin sodium 3 MG Oral Tablet | PSN | 1d47272d-979e-46fe-814f-7b835a0f23d4 | 101 |
| 855318 | warfarin sodium 3 MG Oral Tablet | SCD | 1d47272d-979e-46fe-814f-7b835a0f23d4 | 101 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 57237-122-01 | 57237012201 | 100 TABLET in 1 BOTTLE (57237-122-01) | 100 tablet | 2011-11-11 | 0000-00-00 | No | No | Current |